ZA200904920B - Benzimidazole TRPV1 inhibitors - Google Patents
Benzimidazole TRPV1 inhibitorsInfo
- Publication number
- ZA200904920B ZA200904920B ZA200904920A ZA200904920A ZA200904920B ZA 200904920 B ZA200904920 B ZA 200904920B ZA 200904920 A ZA200904920 A ZA 200904920A ZA 200904920 A ZA200904920 A ZA 200904920A ZA 200904920 B ZA200904920 B ZA 200904920B
- Authority
- ZA
- South Africa
- Prior art keywords
- benzimidazole
- trpv1 inhibitors
- trpv1
- inhibitors
- benzimidazole trpv1
- Prior art date
Links
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
- 102000003566 TRPV1 Human genes 0.000 title 1
- 101150016206 Trpv1 gene Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87021206P | 2006-12-15 | 2006-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200904920B true ZA200904920B (en) | 2010-09-29 |
Family
ID=39536675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200904920A ZA200904920B (en) | 2006-12-15 | 2009-07-14 | Benzimidazole TRPV1 inhibitors |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7612211B2 (xx) |
| EP (1) | EP2124563B1 (xx) |
| JP (1) | JP5746471B2 (xx) |
| KR (1) | KR101503286B1 (xx) |
| AR (1) | AR064356A1 (xx) |
| AU (1) | AU2007333990A1 (xx) |
| BR (1) | BRPI0721169A2 (xx) |
| CA (1) | CA2672856C (xx) |
| CL (1) | CL2007003636A1 (xx) |
| ES (1) | ES2551709T3 (xx) |
| MX (1) | MX2009006473A (xx) |
| NZ (1) | NZ598485A (xx) |
| PE (1) | PE20081383A1 (xx) |
| TW (1) | TWI425943B (xx) |
| UY (1) | UY30787A1 (xx) |
| WO (1) | WO2008076752A1 (xx) |
| ZA (1) | ZA200904920B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7951829B2 (en) * | 2006-05-03 | 2011-05-31 | Janssen Pharmaceutica Nv | Benzimidazole modulators of VR1 |
| US20100144717A1 (en) * | 2006-12-15 | 2010-06-10 | Janelle Comita-Prevoir | 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents |
| CN101868443A (zh) | 2007-09-20 | 2010-10-20 | 特拉维夫大学拉莫特有限公司 | N-苯基邻氨基苯甲酸衍生物及其用途 |
| US8217060B2 (en) | 2009-05-15 | 2012-07-10 | Janssen Pharmaceutica, Nv | Benzimidazole derivatives useful as TRP M8 receptor modulators |
| EP2390245A1 (en) * | 2010-05-26 | 2011-11-30 | Nabriva Therapeutics AG | Enantiomerically pure amines |
| CA2828456C (en) * | 2011-03-03 | 2021-05-04 | Zalicus Pharmaceuticals Ltd. | N-benzl-amino-carboxamide inhibitors of the sodium channel |
| CN104395298A (zh) * | 2012-06-22 | 2015-03-04 | 住友化学株式会社 | 稠合杂环化合物 |
| EP2700431A1 (en) | 2012-08-24 | 2014-02-26 | AnalytiCon Discovery GmbH | Plant extracts for modulating TRPV1 function |
| LT6064B (lt) | 2012-10-15 | 2014-08-25 | Vilniaus Universitetas | Fluorinti benzensulfonamidai kaip karboanhidrazės inhibitoriai |
| EP3547991A1 (en) | 2016-12-02 | 2019-10-09 | Symrise AG | Cosmetic blends |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3182070A (en) * | 1962-05-24 | 1965-05-04 | Dow Chemical Co | Benzimidazole compounds |
| FR2766822B1 (fr) * | 1997-07-30 | 2001-02-23 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6299796B1 (en) | 1997-12-18 | 2001-10-09 | Fuji Photo Film Co., Ltd. | Styryl compound, method for the preparation thereof and electroluminescent element employing the same |
| WO2004014871A1 (en) | 2002-08-08 | 2004-02-19 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| EP1606019A1 (en) | 2003-03-07 | 2005-12-21 | The University Court of The University of Aberdeen | Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
| CN1890223A (zh) | 2003-10-31 | 2007-01-03 | 神经能质公司 | 辣椒素受体促效剂 |
| FR2880625B1 (fr) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| US7429608B2 (en) * | 2005-01-20 | 2008-09-30 | Amgen Inc. | Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments |
| US7951829B2 (en) | 2006-05-03 | 2011-05-31 | Janssen Pharmaceutica Nv | Benzimidazole modulators of VR1 |
-
2007
- 2007-12-12 AU AU2007333990A patent/AU2007333990A1/en not_active Abandoned
- 2007-12-12 US US11/954,647 patent/US7612211B2/en active Active
- 2007-12-12 JP JP2009541552A patent/JP5746471B2/ja active Active
- 2007-12-12 NZ NZ598485A patent/NZ598485A/xx unknown
- 2007-12-12 WO PCT/US2007/087228 patent/WO2008076752A1/en active Application Filing
- 2007-12-12 CA CA2672856A patent/CA2672856C/en active Active
- 2007-12-12 BR BRPI0721169-4A patent/BRPI0721169A2/pt not_active IP Right Cessation
- 2007-12-12 MX MX2009006473A patent/MX2009006473A/es active IP Right Grant
- 2007-12-12 ES ES07865574.3T patent/ES2551709T3/es active Active
- 2007-12-12 KR KR1020097014675A patent/KR101503286B1/ko active IP Right Grant
- 2007-12-12 EP EP07865574.3A patent/EP2124563B1/en active Active
- 2007-12-13 PE PE2007001787A patent/PE20081383A1/es not_active Application Discontinuation
- 2007-12-13 UY UY30787A patent/UY30787A1/es unknown
- 2007-12-14 AR ARP070105626A patent/AR064356A1/es not_active Application Discontinuation
- 2007-12-14 TW TW096147795A patent/TWI425943B/zh not_active IP Right Cessation
- 2007-12-14 CL CL200703636A patent/CL2007003636A1/es unknown
-
2009
- 2009-07-14 ZA ZA200904920A patent/ZA200904920B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20080146637A1 (en) | 2008-06-19 |
| CL2007003636A1 (es) | 2008-06-20 |
| EP2124563A1 (en) | 2009-12-02 |
| AR064356A1 (es) | 2009-04-01 |
| MX2009006473A (es) | 2009-08-25 |
| AU2007333990A1 (en) | 2008-06-26 |
| CA2672856C (en) | 2016-02-02 |
| JP5746471B2 (ja) | 2015-07-08 |
| UY30787A1 (es) | 2008-07-03 |
| ES2551709T3 (es) | 2015-11-23 |
| BRPI0721169A2 (pt) | 2014-03-18 |
| NZ598485A (en) | 2013-08-30 |
| US7612211B2 (en) | 2009-11-03 |
| KR101503286B1 (ko) | 2015-03-17 |
| TWI425943B (zh) | 2014-02-11 |
| EP2124563A4 (en) | 2011-04-20 |
| WO2008076752A1 (en) | 2008-06-26 |
| CA2672856A1 (en) | 2008-06-26 |
| EP2124563B1 (en) | 2015-07-29 |
| JP2010513298A (ja) | 2010-04-30 |
| PE20081383A1 (es) | 2008-09-18 |
| KR20090090386A (ko) | 2009-08-25 |
| TW200843747A (en) | 2008-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2017016I1 (el) | Αναστολεις πρωτεασωματος | |
| DK2041138T3 (da) | Pyrroltriazinkinase-inhibitorer | |
| DK2024375T3 (da) | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | |
| HK1176601A1 (zh) | 抑制劑 | |
| CR10831A (es) | INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA | |
| IL197752A0 (en) | Hdac inhibitors | |
| EP2200439A4 (en) | HDAC INHIBITORS | |
| IL196590A0 (en) | Acrylamide derivatives as fab i inhibitors | |
| ZA200904920B (en) | Benzimidazole TRPV1 inhibitors | |
| IL196067A0 (en) | New cxcr2 inhibitors | |
| PL2383271T3 (pl) | Aminochinolony jako inhibitory GSK-3 | |
| DK2074108T3 (da) | Renin-inhibitorer | |
| EP2088861A4 (en) | BENZIMIDAZOLE COMPOUNDS | |
| DK2066662T3 (da) | Serinhydrolaseinhibitorer | |
| IL196000A0 (en) | 2-arylindole derivatives as npges-i inhibitors | |
| IL193475A0 (en) | Benzimidazole derivatives | |
| EP2131858A4 (en) | P38 INHIBITORS | |
| GB0624187D0 (en) | HDAC inhibitors | |
| IL193981A0 (en) | Novel heterocyclic nf-kb inhibitors | |
| EP2222662A4 (en) | INHIBITORS OF KYNURENINE AMINO TRANSFERASE | |
| EP2177529A4 (en) | NEW DE-SECRETASE INHIBITOR | |
| ATE522533T1 (de) | Pyrazolopyrimidinonkinaseinhibitor | |
| GB0714941D0 (en) | Inhibitors | |
| FI20075320A0 (fi) | Uusia käyttökelpoisia inhibiittoreita | |
| GB0713152D0 (en) | Phosphodlesterase inhibitors |